Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 190

1.

Functional Analysis of Vascularized Collagen/Fibrin Templates by MRI in Vivo.

Sun W, Sun Y, Klar AS, Geutjes PJ, Reichmann E, Heerschap A, Oosterwijk E.

Tissue Eng Part C Methods. 2016 Jun 21. [Epub ahead of print]

PMID:
27324220
2.

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.

De Groot S, Sleijfer S, Redekop WK, Oosterwijk E, Haanen JB, Kiemeney LA, Uyl-de Groot CA.

BMC Cancer. 2016 Jun 11;16:364. doi: 10.1186/s12885-016-2395-x.

3.

Tubular Constructs as Artificial Urinary Conduits.

Sloff M, Simaioforidis V, Tiemessen DM, Janke HP, Kortmann BB, Roelofs LA, Geutjes PJ, Oosterwijk E, Feitz WF.

J Urol. 2016 May 13. pii: S0022-5347(16)30407-4. doi: 10.1016/j.juro.2016.04.092. [Epub ahead of print]

PMID:
27185613
4.

Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based Registry.

de Groot S, Redekop WK, Sleijfer S, Oosterwijk E, Bex A, Kiemeney LA, Uyl-de Groot CA.

Urology. 2016 May 11. pii: S0090-4295(16)30154-6. doi: 10.1016/j.urology.2016.04.042. [Epub ahead of print]

PMID:
27179773
5.

Targeted dual-modality imaging in renal cell carcinoma: An ex vivo kidney perfusion study.

Hekman MC, Boerman OC, de Weijert MC, Bos DL, Oosterwijk E, Langenhuijsen JF, Mulders PF, Rijpkema M.

Clin Cancer Res. 2016 Apr 21. pii: clincanres.2937.2015. [Epub ahead of print]

PMID:
27103404
6.

Novel tubular constructs for urinary diversion: a biocompatibility study in pigs.

Sloff M, Simaioforidis V, Geutjes PJ, Hoogenkamp HR, van Kuppevelt TH, Daamen WF, Oosterwijk E, Feitz WF.

J Tissue Eng Regen Med. 2016 Feb 16. doi: 10.1002/term.2122. [Epub ahead of print]

PMID:
26880718
7.

Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.

Muselaers CH, Boers-Sonderen MJ, van Oostenbrugge TJ, Boerman OC, Desar IM, Stillebroer AB, Mulder SF, van Herpen CM, Langenhuijsen JF, Oosterwijk E, Oyen WJ, Mulders PF.

Eur Urol. 2016 May;69(5):767-70. doi: 10.1016/j.eururo.2015.11.033. Epub 2015 Dec 23.

PMID:
26706103
8.

Bladder Regeneration Using a Smart Acellular Collagen Scaffold with Growth Factors VEGF, FGF2 and HB-EGF.

Roelofs LA, Oosterwijk E, Kortmann BB, Daamen WF, Tiemessen DM, Brouwer KM, Eggink AJ, Crevels AJ, Wijnen RM, van Kuppevelt TH, Geutjes PJ, Feitz WF.

Tissue Eng Part A. 2016 Jan;22(1-2):83-92. doi: 10.1089/ten.TEA.2015.0096. Epub 2015 Dec 1.

PMID:
26441140
9.

Biodistribution of size-selected lyophilisomes in mice.

van Bracht E, Raavé R, Perevyazko IY, Versteeg EM, Hafmans TG, Schubert US, Oosterwijk E, van Kuppevelt TH, Daamen WF.

Eur J Pharm Biopharm. 2015 Aug;94:141-51. doi: 10.1016/j.ejpb.2015.04.020. Epub 2015 May 5.

PMID:
25953331
10.

Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.

Oosterwijk-Wakka JC, de Weijert MC, Franssen GM, Leenders WP, van der Laak JA, Boerman OC, Mulders PF, Oosterwijk E.

Neoplasia. 2015 Feb;17(2):215-24. doi: 10.1016/j.neo.2014.12.011.

11.

Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250.

Muselaers CH, Rijpkema M, Bos DL, Langenhuijsen JF, Oyen WJ, Mulders PF, Oosterwijk E, Boerman OC.

J Urol. 2015 Aug;194(2):532-8. doi: 10.1016/j.juro.2015.02.041. Epub 2015 Feb 14.

PMID:
25686542
12.

Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.

Arends TJ, Falke J, Lammers RJ, Somford DM, Hendriks JC, de Weijert MC, Arentsen HC, van der Heijden AG, Oosterwijk E, Alfred Witjes J.

World J Urol. 2015 Oct;33(10):1411-7. doi: 10.1007/s00345-014-1458-3. Epub 2014 Dec 10.

PMID:
25491674
13.

Recent advances in ureteral tissue engineering.

de Jonge PK, Simaioforidis V, Geutjes PJ, Oosterwijk E, Feitz WF.

Curr Urol Rep. 2015 Jan;16(1):465. doi: 10.1007/s11934-014-0465-7. Review.

14.

Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.

van Bracht E, Versteegden LR, Stolle S, Verdurmen WP, Woestenenk R, Raavé R, Hafmans T, Oosterwijk E, Brock R, van Kuppevelt TH, Daamen WF.

PLoS One. 2014 Nov 4;9(11):e110813. doi: 10.1371/journal.pone.0110813. eCollection 2014. Erratum in: PLoS One. 2015;10(4):e0124465.

15.

Patient and Disease Characteristics are Important Determinants of Health-Related Quality of Life of Patients with Metastatic Renal Cell Carcinoma Results from a Population-Based Registry.

de Groot, Redekop W, Oosterwijk E, Kiemeney L, Uyl-de Groot C.

Value Health. 2014 Nov;17(7):A649. doi: 10.1016/j.jval.2014.08.2355. Epub 2014 Oct 26. No abstract available.

16.

Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer.

Buffen K, Oosting M, Quintin J, Ng A, Kleinnijenhuis J, Kumar V, van de Vosse E, Wijmenga C, van Crevel R, Oosterwijk E, Grotenhuis AJ, Vermeulen SH, Kiemeney LA, van de Veerdonk FL, Chamilos G, Xavier RJ, van der Meer JW, Netea MG, Joosten LA.

PLoS Pathog. 2014 Oct 30;10(10):e1004485. doi: 10.1371/journal.ppat.1004485. eCollection 2014 Oct.

17.

Tissue engineering of diseased bladder using a collagen scaffold in a bladder exstrophy model.

Roelofs LA, Kortmann BB, Oosterwijk E, Eggink AJ, Tiemessen DM, Crevels AJ, Wijnen RM, Daamen WF, van Kuppevelt TH, Geutjes PJ, Feitz WF.

BJU Int. 2014 Sep;114(3):447-57.

PMID:
25302355
18.

Identification of potential bladder progenitor cells in the trigone.

Sun W, Wilhelmina Aalders T, Oosterwijk E.

Dev Biol. 2014 Sep 1;393(1):84-92. doi: 10.1016/j.ydbio.2014.06.018. Epub 2014 Jun 30.

19.

Tissue engineering in animal models for urinary diversion: a systematic review.

Sloff M, de Vries R, Geutjes P, IntHout J, Ritskes-Hoitinga M, Oosterwijk E, Feitz W.

PLoS One. 2014 Jun 25;9(6):e98734. doi: 10.1371/journal.pone.0098734. eCollection 2014. Review. Erratum in: PLoS One. 2014;9(8):e105484.

20.

Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.

van Berkel A, Rao JU, Kusters B, Demir T, Visser E, Mensenkamp AR, van der Laak JA, Oosterwijk E, Lenders JW, Sweep FC, Wevers RA, Hermus AR, Langenhuijsen JF, Kunst DP, Pacak K, Gotthardt M, Timmers HJ.

J Nucl Med. 2014 Aug;55(8):1253-9. doi: 10.2967/jnumed.114.137034. Epub 2014 Jun 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk